Edited sentence: General Anxiety Disorder is frequently mentioned in association with criticisms that pharmaceutical companies are attempting to market ordinary life experiences as "diseases" requiring a "cure", with a profit motive.Major concerns of such campaigns are that they lead people to receive unnecessary treatment (which can do more harm than good), and that potential side effects of such marketed drugs are not properly mentioned.Since the US approval of Paroxetine, for the treatment of GAD in 2001, the disorder has been subjected to extensive marketing campaigns with the key focus on drugs to treat it